MRC1 and neoplasm: Three days after intracerebral injection of mannosylated clodronate liposomes in the metastatic brain, a decrease in MRC1 expression around the tumor foci was observed (Figure 6A), which was statistically significant (unpaired t-test p < 0.05) compared to control liposome injected mice (n = 4 per group; Figure 6B).